Hard proof of how well Oracle's main profit engine is running - join our Conference Call at 2pm CT Wednesday October 22nd. HIDE

Verastem (VSTM)

Add to Watchlists
Create an Alert
9.10 -0.10  -1.09% NASDAQ Oct 21, 11:15AM BATS Real time Currency in USD
View Full Chart
VSTM Price Chart
View All Events

VSTM Events

Date Type Description
08/07/2014 Earnings Q2 2014 Verastem Inc Earnings Release
08/07/2014 Misc Q2 2014 Verastem Inc Earnings Release Conference Call
05/08/2014 Earnings Q1 2014 Verastem Inc Earnings Results
05/05/2014 Misc Annual General Meeting for Verastem Inc
03/06/2014 08:00 EST Misc Verastem Inc Q4 2013 Earnings Conference Call
03/06/2014 Earnings Verastem Inc Q4 2013 Earnings Results
11/12/2013 Earnings Verastem Reports Third Quarter 2013 Financial and Corporate Results
View All Performance Charts

VSTM Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Verastem is down 27.26% over the last year vs S&P 500 Total Return up 12.80%, ARCA biopharma down 26.88%, and Xencor up N/A.

Get Quote for

Portfolio Strategies Featuring VSTM

Did Verastem make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

VSTM Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.verastem.com
  • IR Website: http://phx.corporate-ir.net/phoenix.zhtml?c=250749&p=irol-irhome
  • HQ Country: United States
  • HQ State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: December 31, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Verastem Inc is a biopharmaceutical company engaged in discovering and developing proprietary small molecule drugs targeting cancer stem cells along with proprietary companion diagnostics.

VSTM Excel Add-In Codes

  • Name: =YCI("VSTM","name")
  • Description: =YCI("VSTM","description")
  • Sector: =YCI("VSTM","sector")
  • Industry: =YCI("VSTM","industry")
  • Est. Current Fiscal Year End: =YCI("VSTM","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.